MRP3 MRP3 is a relatively poor transporter of GSH-conjugated organic anions compared to MRP1 and MRP2 [91]
Joint pain, or arthralgia, is not listed among the common adverse effects in the FDA-approved prescribing information for semaglutide formulations
10.1016/j.cellsig.2023.110939 147 XueX.ZhangS.JiangW.WangJ.XinQ.SunC.et al (2021)
In addition, hospitals serve as primary centers for patient education, chronic disease management, and long-term therapy monitoring
Other questions also warrant further research, such as understanding why some patients with OSA dont fully respond to GLP-1 treatments
DOI: 10.1093/qjmed/hct051 Arendt JFH et al, "Elevated vitamin B12 levels and cancer risk in UK primary care: A THIN database cohort study." Cancer Epidemiology, Biomarkers & Prevention, April 2019